{"entity":{"type":"insider","cik":"0001428764","url":"/insider/0001428764","json_url":"/insider/0001428764.json","name":"Drutz David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2012-05-30","last":"2024-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Drutz David","source":"filing","n_filings":10,"first_seen":"2012-05-30","last_seen":"2024-08-20"}],"transactions":[{"id":2284688,"accession":"0001104659-24-091346","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-091346","line_url":"/filing/0001104659-24-091346","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16011.0,"shares_display":"16,011","price_per_share":6.904442570732622,"price_display":"6.90","price_state":"stated","total_value":110547.03,"total_display":"110,547.03","total_whole":"110,547","shares_owned_after":55524.0,"shares_owned_after_display":"55,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":8052718,"accession":"0001104659-23-092080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-092080","line_url":"/filing/0001104659-23-092080#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":2.875,"price_display":"2.88","price_state":"stated","total_value":862.5,"total_display":"862.50","total_whole":"863","shares_owned_after":29785.0,"shares_owned_after_display":"29,785","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-15","scope":"insider"},{"id":8145840,"accession":"0001104659-23-037190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-037190","line_url":"/filing/0001104659-23-037190#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":38430.0,"total_display":"38,430.00","total_whole":"38,430","shares_owned_after":29484.0,"shares_owned_after_display":"29,484","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":6397984,"accession":"0001104659-22-072059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-072059","line_url":"/filing/0001104659-22-072059#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":20012.0,"shares_owned_after_display":"20,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-16","scope":"insider"},{"id":6537088,"accession":"0001104659-22-064786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-064786","line_url":"/filing/0001104659-22-064786#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":19012.0,"shares_owned_after_display":"19,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":4484237,"accession":"0001012975-17-000656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-17-000656","line_url":"/filing/0001012975-17-000656#line-2","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.2679,"price_display":"2.27","price_state":"stated","total_value":11339.5,"total_display":"11,339.50","total_whole":"11,340","shares_owned_after":30777.0,"shares_owned_after_display":"30,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-23","filed_date":"2017-08-24","scope":"insider"},{"id":4484232,"accession":"0001012975-17-000656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-17-000656","line_url":"/filing/0001012975-17-000656#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.1515,"price_display":"2.15","price_state":"stated","total_value":10757.5,"total_display":"10,757.50","total_whole":"10,758","shares_owned_after":25777.0,"shares_owned_after_display":"25,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-22","filed_date":"2017-08-24","scope":"insider"},{"id":5214814,"accession":"0001354488-13-003008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-003008","line_url":"/filing/0001354488-13-003008#line-1","is_derivative":false,"issuer_cik":"0000919745","issuer_name":"DARA BioSciences, Inc.","issuer_ticker":"DARA","issuer_name_source":null,"issuer_url":"/issuer/0000919745","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director, Officer (CEO and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.6976,"price_display":"0.70","price_state":"stated","total_value":17440.0,"total_display":"17,440.00","total_whole":"17,440","shares_owned_after":103072.0,"shares_owned_after_display":"103,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-17","filed_date":"2013-05-20","scope":"insider"},{"id":2152861,"accession":"0001181431-12-050842","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-050842","line_url":"/filing/0001181431-12-050842#line-1","is_derivative":false,"issuer_cik":"0000919745","issuer_name":"DARA BioSciences, Inc.","issuer_ticker":"DARA","issuer_name_source":null,"issuer_url":"/issuer/0000919745","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director, Officer (CEO and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":26500.0,"total_display":"26,500.00","total_whole":"26,500","shares_owned_after":78073.0,"shares_owned_after_display":"78,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-17","filed_date":"2012-09-17","scope":"insider"},{"id":2197552,"accession":"0001181431-12-035783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-035783","line_url":"/filing/0001181431-12-035783#line-1","is_derivative":false,"issuer_cik":"0000919745","issuer_name":"DARA BioSciences, Inc.","issuer_ticker":"DARA","issuer_name_source":null,"issuer_url":"/issuer/0000919745","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director, Officer (CEO and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":19250.0,"total_display":"19,250.00","total_whole":"19,250","shares_owned_after":53073.0,"shares_owned_after_display":"53,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-08","filed_date":"2012-06-11","scope":"insider"},{"id":2088560,"accession":"0001181431-12-033370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-033370","line_url":"/filing/0001181431-12-033370#line-1","is_derivative":false,"issuer_cik":"0000919745","issuer_name":"DARA BioSciences, Inc.","issuer_ticker":"DARA","issuer_name_source":null,"issuer_url":"/issuer/0000919745","owner_cik":"0001428764","owner_name":"Drutz David","owner_display_name":"Drutz David","owner_url":"/insider/0001428764","role":"Director, Officer (CEO and CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.9013,"price_display":"0.90","price_state":"stated","total_value":22532.5,"total_display":"22,532.50","total_whole":"22,533","shares_owned_after":28073.0,"shares_owned_after_display":"28,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"Altimmune, Inc.","url":"/issuer/0001326190","role":"Director","n_filings":6,"first_seen":"2017-08-24","last_seen":"2024-08-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000919745","name":"DARA BioSciences, Inc.","url":"/issuer/0000919745","role":"Director, Officer (CEO and CMO)","n_filings":4,"first_seen":"2012-05-30","last_seen":"2013-05-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001428764","retrieved_at":"2026-08-23T19:16:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}